4Covacci V,Bruzzese N,Maccauro G,et al.ln vitroevaluation of the mutagenic and carcinogenic power of high purity zirconiaceramic [J]. Biomaterials,1999,20(4):371-376.
5Porstendfer J,Reineking A,Wellert H C.Radiation risk estimation based on activity measurements of zirconium oxide implants [J].J Biomed Mater Res, 1996,32(4):663-667.
6Michalakis KX,Hirayama H,Sfolkos Let al.Light transmission of posts and cores used for the anterior esthetic region [J].lnt J Periodontics Restorative Dent,2004,24(5):462-469.
8Xu HH,Quinn JB,Takagi S,et al.Processing and properties of strong and non-rigid calcium phosphate cement [J].J Dent Res,2002,81 (3): 219-224.
9Chen Y,Miao X.Thermal and chemical stability of fluorohydroxyapatite ceramics with different fluorine contenes [J]. Biomaterials,2005,26( 11 ): 1205-1210.
7Manicone PE,Rossi Iommetti P,Raffaelli L.An overview of zirconia ceramics:basic properties and clinical applications [J].J Dent,2007,35: 819-826.
8Fischer H,Weber M,Marx R. Lifetime prediction of all-ceramic bridges by computational Methods[J].J Dent Res,2003,82(3):238-242.
9Covacci V,Bruzzese N,Maccauro G,et al.In vitro evaluation of the mutagenic and carcinogenic power of high purity zirconia ceramic[J]. Biomaterials, 1999, 20:371-376.
10Kim HW,Noh YJ,Koh YH,et al. Effect of CaF2 on densification and properties of hydroxyapatite-zirconia composites for biomedical applications[J].Biomaterials,2002,23(2002):4113-4121.
